Literature DB >> 29372472

Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

China Nagano1, Kandai Nozu2, Naoya Morisada1, Masahiko Yazawa3, Daisuke Ichikawa3, Keita Numasawa4, Hiroyo Kourakata5, Chieko Matsumura6, Satoshi Tazoe7, Ryojiro Tanaka8, Tomohiko Yamamura1, Shogo Minamikawa1, Tomoko Horinouchi1, Keita Nakanishi1, Junya Fujimura1, Nana Sakakibara1, Yoshimi Nozu1, Ming Juan Ye1, Hiroshi Kaito1, Kazumoto Iijima1.   

Abstract

BACKGROUND: Comprehensive genetic approaches for diagnosing inherited kidney diseases using next-generation sequencing (NGS) have recently been established. However, even with these approaches, we are still failing to detect gene defects in some patients who appear to suffer from genetic diseases. One of the reasons for this is the difficulty of detecting copy number variations (CNVs) using our current approaches. For such cases, we can apply methods of array-based comparative genomic hybridization (aCGH) or multiplex ligation and probe amplification (MLPA); however, these are expensive and laborious and also often fail to identify CNVs. Here, we report seven cases with CNVs in various inherited kidney diseases screened by NGS pair analysis.
METHODS: Targeted sequencing analysis for causative genes was conducted for cases with suspected inherited kidney diseases, for some of which a definitive genetic diagnosis had not been achieved. We conducted pair analysis using NGS data for those cases. When CNVs were detected by pair analysis, they were confirmed by aCGH and/or MLPA.
RESULTS: In seven cases, CNVs in various causative genes of inherited kidney diseases were detected by pair analysis. With aCGH and/or MLPA, pathogenic CNV variants were confirmed: COL4A5 or HNF1B in two cases each, and EYA1, CLCNKB, or PAX2 in one each.
CONCLUSION: We presented seven cases with CNVs in various genes that were screened by pair analysis. The NGS-based CNV detection method is useful for comprehensive screening of CNVs, and our results revealed that, for a certain proportion of cases, CNV analysis is necessary for accurate genetic diagnosis.

Entities:  

Keywords:  Alport syndrome; BOR syndrome; Bartter syndrome; Gitelman syndrome; Inherited kidney disease; Renal coloboma syndrome

Mesh:

Year:  2018        PMID: 29372472     DOI: 10.1007/s10157-018-1534-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  15 in total

Review 1.  Advances in renal genetic diagnosis.

Authors:  Carsten Bergmann
Journal:  Cell Tissue Res       Date:  2017-06-09       Impact factor: 5.249

2.  Accurate and exact CNV identification from targeted high-throughput sequence data.

Authors:  Alex S Nord; Ming Lee; Mary-Claire King; Tom Walsh
Journal:  BMC Genomics       Date:  2011-04-12       Impact factor: 3.969

3.  CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.

Authors:  Getiria Onsongo; Linda B Baughn; Matthew Bower; Christine Henzler; Matthew Schomaker; Kevin A T Silverstein; Bharat Thyagarajan
Journal:  J Mol Diagn       Date:  2016-09-03       Impact factor: 5.568

4.  Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Authors:  Laurent Castéra; Sophie Krieger; Antoine Rousselin; Angélina Legros; Jean-Jacques Baumann; Olivia Bruet; Baptiste Brault; Robin Fouillet; Nicolas Goardon; Olivier Letac; Stéphanie Baert-Desurmont; Julie Tinat; Odile Bera; Catherine Dugast; Pascaline Berthet; Florence Polycarpe; Valérie Layet; Agnes Hardouin; Thierry Frébourg; Dominique Vaur
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

5.  Human copy number variation and complex genetic disease.

Authors:  Santhosh Girirajan; Catarina D Campbell; Evan E Eichler
Journal:  Annu Rev Genet       Date:  2011-08-19       Impact factor: 16.830

6.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Authors:  Carolin E Sadowski; Svjetlana Lovric; Shazia Ashraf; Werner L Pabst; Heon Yung Gee; Stefan Kohl; Susanne Engelmann; Virginia Vega-Warner; Humphrey Fang; Jan Halbritter; Michael J Somers; Weizhen Tan; Shirlee Shril; Inès Fessi; Richard P Lifton; Detlef Bockenhauer; Sherif El-Desoky; Jameela A Kari; Martin Zenker; Markus J Kemper; Dominik Mueller; Hanan M Fathy; Neveen A Soliman; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

7.  Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.

Authors:  Anna Fowler; Shazia Mahamdallie; Elise Ruark; Sheila Seal; Emma Ramsay; Matthew Clarke; Imran Uddin; Harriet Wylie; Ann Strydom; Gerton Lunter; Nazneen Rahman
Journal:  Wellcome Open Res       Date:  2016-11-25

Review 8.  Genetics of Congenital Anomalies of the Kidney and Urinary Tract: The Current State of Play.

Authors:  Valentina P Capone; William Morello; Francesca Taroni; Giovanni Montini
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

9.  X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.

Authors:  Judith Savige; Helen Storey; Hae Il Cheong; Hee Gyung Kang; Eujin Park; Pascale Hilbert; Anton Persikov; Carmen Torres-Fernandez; Elisabet Ars; Roser Torra; Jens Michael Hertz; Mads Thomassen; Lev Shagam; Dongmao Wang; Yanyan Wang; Frances Flinter; Mato Nagel
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

10.  Potential and pitfalls in the genetic diagnosis of kidney diseases.

Authors:  Anne Kesselheim; Emma Ashton; Detlef Bockenhauer
Journal:  Clin Kidney J       Date:  2017-07-18
View more
  9 in total

1.  First genome-wide CNV mapping in FELIS CATUS using next generation sequencing data.

Authors:  F Genova; M Longeri; L A Lyons; A Bagnato; M G Strillacci
Journal:  BMC Genomics       Date:  2018-12-10       Impact factor: 3.969

2.  INDEX-db: The Indian Exome Reference Database (Phase I).

Authors:  Husayn Ahmed P; Vidhya V; Ravi Prabhakar More; Biju Viswanath; Sanjeev Jain; Mahendra S Rao; Odity Mukherjee
Journal:  J Comput Biol       Date:  2019-01-07       Impact factor: 1.479

3.  Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome.

Authors:  Tomohiko Yamamura; Kandai Nozu; Shogo Minamikawa; Tomoko Horinouchi; Nana Sakakibara; China Nagano; Yuya Aoto; Shinya Ishiko; Koichi Nakanishi; Yuko Shima; Hiroaki Nagase; Rini Rossanti; Ming J Ye; Yoshimi Nozu; Shingo Ishimori; Naoya Morisada; Hiroshi Kaito; Kazumoto Iijima
Journal:  Mol Genet Genomic Med       Date:  2019-07-30       Impact factor: 2.183

4.  Comprehensive genetic diagnosis of Japanese patients with severe proteinuria.

Authors:  China Nagano; Tomohiko Yamamura; Tomoko Horinouchi; Yuya Aoto; Shinya Ishiko; Nana Sakakibara; Yuko Shima; Koichi Nakanishi; Hiroaki Nagase; Kazumoto Iijima; Kandai Nozu
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

5.  Clinical features of autosomal recessive polycystic kidney disease in the Japanese population and analysis of splicing in PKHD1 gene for determination of phenotypes.

Authors:  Shinya Ishiko; Naoya Morisada; Atsushi Kondo; Sadayuki Nagai; Yuya Aoto; Eri Okada; Rini Rossanti; Nana Sakakibara; China Nagano; Tomoko Horinouchi; Tomohiko Yamamura; Takeshi Ninchoji; Hiroshi Kaito; Riku Hamada; Yuko Shima; Koichi Nakanishi; Masafumi Matsuo; Kazumoto Iijima; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2021-09-18       Impact factor: 2.801

Review 6.  The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome.

Authors:  Tomohiko Yamamura; Tomoko Horinouchi; Yuya Aoto; Rachel Lennon; Kandai Nozu
Journal:  Front Med (Lausanne)       Date:  2022-02-08

7.  Clinical application of a phenotype-based NGS panel for differential diagnosis of inherited kidney disease and beyond.

Authors:  Jiyoung Oh; Jae Il Shin; Keumwha Lee; CheolHo Lee; Younhee Ko; Jin-Sung Lee
Journal:  Clin Genet       Date:  2020-12-07       Impact factor: 4.438

Review 8.  Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.

Authors:  Kandai Nozu; Yutaka Takaoka; Hirofumi Kai; Minoru Takasato; Kensuke Yabuuchi; Tomohiko Yamamura; Tomoko Horinouchi; Nana Sakakibara; Takeshi Ninchoji; China Nagano; Kazumoto Iijima
Journal:  Kidney Res Clin Pract       Date:  2020-12-31

9.  mRNA analysis identifies deep intronic variants causing Alport syndrome and overcomes the problem of negative results of exome sequencing.

Authors:  Xiaoyuan Wang; Yanqin Zhang; Jie Ding; Fang Wang
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.